K Miura, Y Flores-Garcia, CA Long… - Clinical Microbiology …, 2024 - Am Soc Microbiol
Malaria remains one of the biggest health problems in the world. While significant reductions in malaria morbidity and mortality had been achieved from 2000 to 2015, the favorable trend …
RL Spreng, KE Seaton, L Lin, GQ Horn, M Abraha… - JCI …, 2024 - pmc.ncbi.nlm.nih.gov
BACKGROUND The mechanism (s) responsible for the efficacy of WHO-recommended malaria vaccine RTS, S/AS01 are not completely understood. We previously identified RTS …
Despite various public health strategies, malaria caused by Plasmodium falciparum parasites remains a major global health challenge that requires development of new …
Label-free techniques including Surface Plasmon Resonance (SPR) and Biolayer Interferometry (BLI) are biophysical tools widely used to collect binding kinetics data of …
Y Yang, NC Dalvie, JR Brady… - Biotechnology and …, 2024 - Wiley Online Library
Monoclonal antibodies (mAbs) are a major class of biopharmaceuticals manufactured by well‐established processes using Chinese Hamster Ovary (CHO) cells. Next‐generation …
The protective capacity of antibodies targeting circumsporozoite protein on sporozoites of the malaria parasite Plasmodium falciparum (PfCSP) is linked to high affinity and cross …
Seventy-two intentionally sequence-diverse antibody variable regions were selected, expressed as IgG1 antibodies, and evaluated by chemical unfolding to survey the …
LT Wang, AJR Cooper, B Farrell, K Miura, A Diouf… - Cell, 2024 - cell.com
Plasmodium falciparum reticulocyte-binding protein homolog 5 (RH5) is the most advanced blood-stage malaria vaccine candidate and is being evaluated for efficacy in endemic …
Biopharmaceutical products constitute a significant portion of the global bioeconomy. Compared to traditional synthetic small-molecule drugs, recombinant therapeutic proteins …